Jiangsu Nhwa Pharmaceutical Co., LTD (SHE: 002262)

Jiangsu Nhwa Pharmaceutical Co., LTD Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 9, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	27,376	27,326	24,736	15,769	16,092	11,855
Market Cap Growth	-23.00%	10.47%	56.87%	-2.01%	35.74%	28.86%
Enterprise Value	23,967	23,972	21,956	13,322	13,929	11,014
Last Close Price	26.94	26.77	24.06	15.09	15.31	11.08
PE Ratio	24.26	25.99	27.04	19.11	21.26	16.78
PS Ratio	5.03	5.42	5.75	4.01	4.79	2.86
PB Ratio	4.03	4.26	4.43	3.22	3.92	3.29
P/FCF Ratio	36.40	43.08	46.39	31.86	16.43	81.38
P/OCF Ratio	20.20	27.10	28.73	22.49	12.89	38.75
EV/Sales Ratio	4.43	4.75	5.11	3.38	4.14	2.65
EV/EBITDA Ratio	17.80	19.90	21.43	13.88	15.86	14.19
EV/EBIT Ratio	20.41	22.41	24.35	15.72	17.82	16.01
EV/FCF Ratio	31.87	37.79	41.17	26.91	14.22	75.61
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.01	0.01
Debt / EBITDA Ratio	0.10	0.09	0.09	0.11	0.04	0.05
Debt / FCF Ratio	0.18	0.18	0.17	0.22	0.04	0.26
Asset Turnover	0.75	0.73	0.71	0.75	0.75	1.01
Inventory Turnover	2.43	2.09	1.57	1.80	2.16	4.13
Quick Ratio	5.90	5.64	4.88	5.01	4.99	5.08
Current Ratio	6.62	6.46	5.86	5.93	5.77	5.82
Return on Equity (ROE)	17.66%	17.25%	16.78%	17.72%	18.86%	20.03%
Return on Assets (ROA)	10.14%	9.68%	9.25%	10.14%	10.92%	10.45%
Return on Capital (ROIC)	11.41%	10.96%	10.54%	11.56%	12.55%	12.43%
Earnings Yield	4.12%	3.79%	3.64%	5.06%	4.53%	5.59%
FCF Yield	2.75%	2.32%	2.16%	3.14%	6.09%	1.23%
Dividend Yield	1.17%	1.20%	0.83%	1.33%	0.65%	0.90%
Payout Ratio	28.91%	19.43%	22.37%	12.63%	13.98%	11.63%
Buyback Yield / Dilution	-0.17%	0.53%	-0.22%	0.24%	-0.72%	0.42%
Total Shareholder Return	1.00%	1.72%	0.61%	1.56%	-0.07%	1.32%

Source: S&P Capital IQ. Standard template. Financial Sources.